European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

4 EU fundings (€1,698,065): Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions … BdlYear 2019 EU Research and Innovation programme "Horizon"

Text

Philipps-Universität Marburg, Marburg, Germany

28/08/2019 EU funding (€201,565): Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions
01/01/2019 EU funding (€293,438): Palliative care in Parkinson’s disease
01/01/2019 EU funding (€500,000): Privacy preserving federated machine learning and blockchaining for reduced cyber risks in a world of distributed healthcare
01/01/2019 EU funding (€703,063): Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response.

DATA SERVICES

Unlock the full potential of processed company data with our API or Quarterly Exports.

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Philipps-Universität Marburg, Marburg, Germany.

Creative Commons License The visualizations for "Philipps-Universität Marburg - 4 EU fundings (€1,698,065): Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.